Cargando…

Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device

BACKGROUND: Sequence verification is essential for plasmids used as critical reagents or therapeutic products. Typically, high-quality plasmid sequence is achieved through capillary-based Sanger sequencing, requiring customized sets of primers for each plasmid. This process can become expensive, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Scott D., Dreolini, Lisa, Wilson, Jessica F., Balasundaram, Miruna, Holt, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039527/
https://www.ncbi.nlm.nih.gov/pubmed/36964503
http://dx.doi.org/10.1186/s12859-023-05226-y
_version_ 1784912287102926848
author Brown, Scott D.
Dreolini, Lisa
Wilson, Jessica F.
Balasundaram, Miruna
Holt, Robert A.
author_facet Brown, Scott D.
Dreolini, Lisa
Wilson, Jessica F.
Balasundaram, Miruna
Holt, Robert A.
author_sort Brown, Scott D.
collection PubMed
description BACKGROUND: Sequence verification is essential for plasmids used as critical reagents or therapeutic products. Typically, high-quality plasmid sequence is achieved through capillary-based Sanger sequencing, requiring customized sets of primers for each plasmid. This process can become expensive, particularly for applications where the validated sequence needs to be produced within a regulated and quality-controlled environment for downstream clinical research applications. RESULTS: Here, we describe a cost-effective and accurate plasmid sequencing and consensus generation procedure using the Oxford Nanopore Technologies’ MinION device as an alternative to capillary-based plasmid sequencing options. This procedure can verify the identity of a pure population of plasmid, either confirming it matches the known and expected sequence, or identifying mutations present in the plasmid if any exist. We use a full MinION flow cell per plasmid, maximizing available data and allowing for stringent quality filters. Pseudopairing reads for consensus base calling reduces read error rates from 5.3 to 0.53%, and our pileup consensus approach provides per-base counts and confidence scores, allowing for interpretation of the certainty of the resulting consensus sequences. For pure plasmid samples, we demonstrate 100% accuracy in the resulting consensus sequence, and the sensitivity to detect small mutations such as insertions, deletions, and single nucleotide variants. In test cases where the sequenced pool of plasmids contains subclonal templates, detection sensitivity is similar to that of traditional capillary sequencing. CONCLUSIONS: Our pipeline can provide significant cost savings compared to outsourcing clinical-grade sequencing of plasmids, making generation of high-quality plasmid sequence for clinical sequence verification more accessible. While other long-read-based methods offer higher-throughput and less cost, our pipeline produces complete and accurate sequence verification for cases where absolute sequence accuracy is required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05226-y.
format Online
Article
Text
id pubmed-10039527
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100395272023-03-26 Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device Brown, Scott D. Dreolini, Lisa Wilson, Jessica F. Balasundaram, Miruna Holt, Robert A. BMC Bioinformatics Research BACKGROUND: Sequence verification is essential for plasmids used as critical reagents or therapeutic products. Typically, high-quality plasmid sequence is achieved through capillary-based Sanger sequencing, requiring customized sets of primers for each plasmid. This process can become expensive, particularly for applications where the validated sequence needs to be produced within a regulated and quality-controlled environment for downstream clinical research applications. RESULTS: Here, we describe a cost-effective and accurate plasmid sequencing and consensus generation procedure using the Oxford Nanopore Technologies’ MinION device as an alternative to capillary-based plasmid sequencing options. This procedure can verify the identity of a pure population of plasmid, either confirming it matches the known and expected sequence, or identifying mutations present in the plasmid if any exist. We use a full MinION flow cell per plasmid, maximizing available data and allowing for stringent quality filters. Pseudopairing reads for consensus base calling reduces read error rates from 5.3 to 0.53%, and our pileup consensus approach provides per-base counts and confidence scores, allowing for interpretation of the certainty of the resulting consensus sequences. For pure plasmid samples, we demonstrate 100% accuracy in the resulting consensus sequence, and the sensitivity to detect small mutations such as insertions, deletions, and single nucleotide variants. In test cases where the sequenced pool of plasmids contains subclonal templates, detection sensitivity is similar to that of traditional capillary sequencing. CONCLUSIONS: Our pipeline can provide significant cost savings compared to outsourcing clinical-grade sequencing of plasmids, making generation of high-quality plasmid sequence for clinical sequence verification more accessible. While other long-read-based methods offer higher-throughput and less cost, our pipeline produces complete and accurate sequence verification for cases where absolute sequence accuracy is required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05226-y. BioMed Central 2023-03-24 /pmc/articles/PMC10039527/ /pubmed/36964503 http://dx.doi.org/10.1186/s12859-023-05226-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Brown, Scott D.
Dreolini, Lisa
Wilson, Jessica F.
Balasundaram, Miruna
Holt, Robert A.
Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title_full Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title_fullStr Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title_full_unstemmed Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title_short Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device
title_sort complete sequence verification of plasmid dna using the oxford nanopore technologies’ minion device
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039527/
https://www.ncbi.nlm.nih.gov/pubmed/36964503
http://dx.doi.org/10.1186/s12859-023-05226-y
work_keys_str_mv AT brownscottd completesequenceverificationofplasmiddnausingtheoxfordnanoporetechnologiesminiondevice
AT dreolinilisa completesequenceverificationofplasmiddnausingtheoxfordnanoporetechnologiesminiondevice
AT wilsonjessicaf completesequenceverificationofplasmiddnausingtheoxfordnanoporetechnologiesminiondevice
AT balasundarammiruna completesequenceverificationofplasmiddnausingtheoxfordnanoporetechnologiesminiondevice
AT holtroberta completesequenceverificationofplasmiddnausingtheoxfordnanoporetechnologiesminiondevice